ATE238989T1 - Verfahren zur herstellung von spiro((4- cyclohexanon)-(3h)indol)-2'(1'h)-on derivaten - Google Patents

Verfahren zur herstellung von spiro((4- cyclohexanon)-(3h)indol)-2'(1'h)-on derivaten

Info

Publication number
ATE238989T1
ATE238989T1 AT00949825T AT00949825T ATE238989T1 AT E238989 T1 ATE238989 T1 AT E238989T1 AT 00949825 T AT00949825 T AT 00949825T AT 00949825 T AT00949825 T AT 00949825T AT E238989 T1 ATE238989 T1 AT E238989T1
Authority
AT
Austria
Prior art keywords
sup
sub
group
general formula
defined above
Prior art date
Application number
AT00949825T
Other languages
English (en)
Inventor
Csaba Goenczi
S Va Csik
Istvan Hermecz
Ja Gergely H
R Rpad Ill
Lajos Nagy
Nt N Csutor Andrea S
Attila Simon
Kalman Simon
N Esek Gota Smelk
Tiborne Szomor
Gyoergyne Szvoboda
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Application granted granted Critical
Publication of ATE238989T1 publication Critical patent/ATE238989T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/96Spiro-condensed ring systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT00949825T 1999-07-15 2000-07-13 Verfahren zur herstellung von spiro((4- cyclohexanon)-(3h)indol)-2'(1'h)-on derivaten ATE238989T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9902374A HUP9902374A3 (en) 1999-07-15 1999-07-15 Process for producing spiro[(4-cyclohexanone)-[3h]indol-2'[1'h]-on derivatives and intermediates
PCT/HU2000/000081 WO2001005760A2 (en) 1999-07-15 2000-07-13 New process for the preparation of spiro [(4-cyclohexanone)-[3h]indol]-2'[1'h]-one derivatives

Publications (1)

Publication Number Publication Date
ATE238989T1 true ATE238989T1 (de) 2003-05-15

Family

ID=89998733

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00949825T ATE238989T1 (de) 1999-07-15 2000-07-13 Verfahren zur herstellung von spiro((4- cyclohexanon)-(3h)indol)-2'(1'h)-on derivaten

Country Status (17)

Country Link
US (2) US6573386B1 (de)
EP (1) EP1200404B1 (de)
JP (1) JP2003505371A (de)
CN (1) CN1149194C (de)
AT (1) ATE238989T1 (de)
AU (1) AU6308400A (de)
BR (1) BR0012473B1 (de)
CA (1) CA2378201C (de)
CZ (1) CZ2002147A3 (de)
DE (1) DE60002472T2 (de)
ES (1) ES2197106T3 (de)
HR (1) HRP20020143B1 (de)
HU (1) HUP9902374A3 (de)
MX (1) MXPA01013341A (de)
PL (1) PL198521B1 (de)
SK (1) SK286875B6 (de)
WO (1) WO2001005760A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7638548B2 (en) * 2006-11-09 2009-12-29 Hoffmann-La Roche Inc. Spiroindolinone derivatives
TW201607923A (zh) 2014-07-15 2016-03-01 歌林達有限公司 被取代之氮螺環(4.5)癸烷衍生物
CA2955071A1 (en) 2014-07-15 2016-01-21 Grunenthal Gmbh Substituted azaspiro(4.5)decane derivatives

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3395156A (en) 1965-08-16 1968-07-30 American Home Prod 1'-phenylspiro (cyclohexane-1, 3'-indoline)-2', 4-dione
US5663431A (en) * 1992-01-30 1997-09-02 Sanofi 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present
US5849780A (en) * 1992-01-30 1998-12-15 Sanofi 1-benzenesulfonyl-1-1,3-dihydroindol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present
US5686624A (en) * 1992-01-30 1997-11-11 Sanofi 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present
FR2740136B1 (fr) * 1995-10-24 1998-01-09 Sanofi Sa Derives d'indolin-2-one, procede pour leur preparation et les compositions pharmaceutiques les contenant
GB9707800D0 (en) * 1996-05-06 1997-06-04 Zeneca Ltd Chemical compounds
FR2757157B1 (fr) * 1996-12-13 1999-12-31 Sanofi Sa Derives d'indolin-2-one, procede pour leur preparation et compositions pharmaceutiques les contenant
WO1999032489A1 (en) * 1997-12-23 1999-07-01 Alcon Laboratories, Inc. Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions

Also Published As

Publication number Publication date
WO2001005760A2 (en) 2001-01-25
US6884895B2 (en) 2005-04-26
JP2003505371A (ja) 2003-02-12
CA2378201A1 (en) 2001-01-25
WO2001005760A3 (en) 2001-07-19
EP1200404B1 (de) 2003-05-02
ES2197106T3 (es) 2004-01-01
SK482002A3 (en) 2003-05-02
DE60002472D1 (de) 2003-06-05
HUP9902374A3 (en) 2002-11-28
PL352477A1 (en) 2003-08-25
PL198521B1 (pl) 2008-06-30
US6573386B1 (en) 2003-06-03
BR0012473B1 (pt) 2011-05-03
CN1360576A (zh) 2002-07-24
SK286875B6 (sk) 2009-07-06
US20030212278A1 (en) 2003-11-13
HRP20020143B1 (en) 2010-11-30
DE60002472T2 (de) 2004-02-26
HRP20020143A2 (en) 2003-10-31
EP1200404A2 (de) 2002-05-02
CZ2002147A3 (cs) 2003-02-12
HU9902374D0 (en) 1999-10-28
MXPA01013341A (es) 2002-08-12
BR0012473A (pt) 2002-04-02
CN1149194C (zh) 2004-05-12
CA2378201C (en) 2007-10-16
HUP9902374A2 (hu) 2001-05-28
AU6308400A (en) 2001-02-05

Similar Documents

Publication Publication Date Title
Roth et al. Inhibitors of cholesterol biosynthesis. 3. Tetrahydro-4-hydroxy-6-[2-(1H-pyrrol-1-yl) ethyl]-2H-pyran 2-one inhibitors of HMG-CoA reductase. 2. Effects of introducing substituents at positions three and four of the pyrrole nucleus
JP2983248B2 (ja) マレインイミド誘導体および医薬としてのそれらの使用
JP2983231B2 (ja) インドロカルバゾル誘導体、その調製方法および薬剤としての使用
CH674368A5 (de)
ATE238989T1 (de) Verfahren zur herstellung von spiro((4- cyclohexanon)-(3h)indol)-2'(1'h)-on derivaten
CZ284561B6 (cs) Způsob přípravy fysostigminkarbamátových derivátů z eseretholů
CZ2001434A3 (cs) Způsob výroby chinolizin-3-onových derivátů
AU605235B2 (en) Alkylmelatonins
UA67724C2 (en) Benzo[c]quinolizine derivatives, a method for the preparation thereof, a pharmaceutical composition and a method for the treatment of pathologies connected with 5 alpha-reductases
EP0894796B1 (de) Durch einen heterocyclischen Ring substituierte Imidazoline als alpha-2 Antagonisten
US5739114A (en) Immunosuppressive cyclolignan derivatives
CA2323703C (fr) Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP0606382B1 (de) 1,8-benzonaphthyridinderivate und antimikrobielle zusammensetzungen
NO833944L (no) Indolderivater, fremgangsmaate til deres fremstilling og deres anvendelse
KR0153530B1 (ko) 락탐 유도체의 제조 방법
CN112174938A (zh) 4-吲哚-2-氨基嘧啶类化合物及其应用
KR100451413B1 (ko) 클루이베로마이시스 마르시아누스의 카르보닐 환원효소를이용한 카르보닐 화합물의 환원반응
HUP0201570A2 (en) New process for the preparation of spiro [(4-cyclohexanone)-[3h]indol]-2'[1'h]-one derivatives
Winslow A methods development approach towards the Galanthan skeleton starting with isoquinoline
HU225703B1 (en) Process for producing spiro[cis-4-(betha-hydroxy-ethyloxi)-cyclohexane-[3h]indole]-2'[1'h]-one derivatives

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties